Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 317

1.

Quantitative assessment of interim PET in Hodgkin lymphoma: An evaluation of the qPET method in adult patients in the RAPID trial.

Georgi TW, Kurch L, Hasenclever D, Warbey VS, Pike L, Radford J, Sabri O, Kluge R, Barrington SF.

PLoS One. 2020 Apr 2;15(4):e0231027. doi: 10.1371/journal.pone.0231027. eCollection 2020.

2.

Allogeneic Hematopoietic Stem Cell Transplantation in a Rare Case of Tonsillar Mast Cell Sarcoma.

Kubasch AS, Franke GN, Aldaoud A, Weibl K, Jentzsch M, Sabri O, Horny HP, Fend F, Behre G, Platzbecker U, Vucinic V.

Front Oncol. 2020 Feb 28;10:219. doi: 10.3389/fonc.2020.00219. eCollection 2020.

3.

Adult attention-deficit/hyperactivity disorder is associated with reduced norepinephrine transporter availability in right attention networks: a (S,S)-O-[11C]methylreboxetine positron emission tomography study.

Ulke C, Rullmann M, Huang J, Luthardt J, Becker GA, Patt M, Meyer PM, Tiepolt S, Hesse S, Sabri O, Strauß M.

Transl Psychiatry. 2019 Nov 15;9(1):301. doi: 10.1038/s41398-019-0619-y.

4.

Current radiotracers to image neurodegenerative diseases.

Tiepolt S, Patt M, Aghakhanyan G, Meyer PM, Hesse S, Barthel H, Sabri O.

EJNMMI Radiopharm Chem. 2019 Jul 26;4(1):17. doi: 10.1186/s41181-019-0070-7. Review.

5.

Posterior wall acetabular fracture fixation: A mechanical analysis of fixation methods.

Pease F, Ward AJ, Stevenson AJ, Cunningham JL, Sabri O, Acharya M, Chesser T.

J Orthop Surg (Hong Kong). 2019 Sep-Dec;27(3):2309499019859838. doi: 10.1177/2309499019859838.

PMID:
31311424
6.

Combined parameter SUVmax/ADCmean predicts microvessel density in head and neck squamous cell carcinoma. Preliminary results.

Surov A, Meyer HJ, Höhn AK, Wienke A, Sabri O, Purz S.

Oral Oncol. 2020 Feb;101:104355. doi: 10.1016/j.oraloncology.2019.06.036. Epub 2019 Jul 3. No abstract available.

PMID:
31279650
7.

In vitro and in vivo Human Metabolism of (S)-[18F]Fluspidine - A Radioligand for Imaging σ1 Receptors With Positron Emission Tomography (PET).

Ludwig FA, Fischer S, Houska R, Hoepping A, Deuther-Conrad W, Schepmann D, Patt M, Meyer PM, Hesse S, Becker GA, Zientek FR, Steinbach J, Wünsch B, Sabri O, Brust P.

Front Pharmacol. 2019 Jun 13;10:534. doi: 10.3389/fphar.2019.00534. eCollection 2019.

8.

Four-repeat tauopathies.

Rösler TW, Tayaranian Marvian A, Brendel M, Nykänen NP, Höllerhage M, Schwarz SC, Hopfner F, Koeglsperger T, Respondek G, Schweyer K, Levin J, Villemagne VL, Barthel H, Sabri O, Müller U, Meissner WG, Kovacs GG, Höglinger GU.

Prog Neurobiol. 2019 Sep;180:101644. doi: 10.1016/j.pneurobio.2019.101644. Epub 2019 Jun 22. Review.

PMID:
31238088
9.

Comparison of 18F-florbetaben quantification results using the standard Centiloid, MR-based, and MR-less CapAIBL® approaches: Validation against histopathology.

Doré V, Bullich S, Rowe CC, Bourgeat P, Konate S, Sabri O, Stephens AW, Barthel H, Fripp J, Masters CL, Dinkelborg L, Salvado O, Villemagne VL, De Santi S.

Alzheimers Dement. 2019 Jun;15(6):807-816. doi: 10.1016/j.jalz.2019.02.005. Epub 2019 May 14.

PMID:
31101517
10.

Transhepatic intraductal radiofrequency ablation of a biliary papillary mucinous neoplasm.

Hollenbach M, Feisthammel J, Mössner J, Schlosser T, Kahn T, Sabri O, Hoffmeister A.

Endoscopy. 2019 Sep;51(9):897-898. doi: 10.1055/a-0889-7116. Epub 2019 May 9. No abstract available.

PMID:
31071744
11.

Citalopram Improves Obsessive-Compulsive Crossword Puzzling in Frontotemporal Dementia.

Meyer S, Mueller K, Gruenewald C, Grundl K, Marschhauser A, Tiepolt S, Barthel H, Sabri O, Schroeter ML.

Case Rep Neurol. 2019 Mar 19;11(1):94-105. doi: 10.1159/000495561. eCollection 2019 Jan-Apr.

12.

18F-FDG-PET Can Predict Microvessel Density in Head and Neck Squamous Cell Carcinoma.

Surov A, Meyer HJ, Höhn AK, Wienke A, Sabri O, Purz S.

Cancers (Basel). 2019 Apr 15;11(4). pii: E543. doi: 10.3390/cancers11040543.

13.

Retroperitoneal space-occupying lesion with displacement of the inferior vena cava.

Niebisch S, Staab H, Ullrich S, Hoffmann KT, Sabri O, Thieme R, Schierle K, Wittekind C, Gockel I.

Int J Surg Case Rep. 2019;57:170-174. doi: 10.1016/j.ijscr.2019.03.037. Epub 2019 Mar 30.

14.

Impact of rs12917 MGMT Polymorphism on [18F]FDG-PET Response in Pediatric Hodgkin Lymphoma (PHL).

Kewitz-Hempel S, Kurch L, Cepelova M, Volkmer I, Sauerbrey A, Conrad E, Knirsch S, Pöpperl G, Steinbach D, Beer AJ, Kramm CM, Sahlmann CO, Erdlenbruch B, Reinbold WD, Odparlik A, Sabri O, Kluge R, Staege MS.

Mol Imaging Biol. 2019 Dec;21(6):1182-1191. doi: 10.1007/s11307-019-01350-5.

PMID:
30945122
15.

[Dopamine Transporter SPECT with I-123 labelled FP-CIT (DaTSCANTM)].

Tatsch K, Buchert R, Bartenstein P, Barthel H, Boecker H, Brust P, Drzezga A, la Fougère C, Gründer G, Grünwald F, Krause BJ, Kuwert T, Langen KJ, Rominger A, Sabri O, Schreckenberger M, Meyer PT.

Nuklearmedizin. 2019 Feb;58(1):5-16. doi: 10.1055/a-0807-8137. Epub 2019 Feb 15. German.

PMID:
30769368
16.

Early after Administration [11C]PiB PET Images Correlate with Cognitive Dysfunction Measured by the CERAD Test Battery.

Tiepolt S, Luthardt J, Patt M, Hesse S, Hoffmann KT, Weise D, Gertz HJ, Sabri O, Barthel H.

J Alzheimers Dis. 2019;68(1):65-76. doi: 10.3233/JAD-180217.

PMID:
30636731
17.

Metabolo-volumetric parameters of 18F-FDG-PET can predict expression of EGFR and HIF 1alpha in uterine cervical cancer.

Surov A, Meyer HJ, Höhn AK, Schob S, Winter K, Sabri O, Purz S.

Cancer Biomark. 2019;24(1):135-140. doi: 10.3233/CBM-182019.

PMID:
30530968
18.

Only strongly enhanced residual FDG uptake in early response PET (Deauville 5 or qPET ≥ 2) is prognostic in pediatric Hodgkin lymphoma: Results of the GPOH-HD2002 trial.

Kurch L, Hasenclever D, Kluge R, Georgi T, Tchavdarova L, Golombeck M, Sabri O, Eggert A, Brenner W, Sykora KW, Bengel FM, Rossig C, Körholz D, Schäfers M, Feuchtinger T, Bartenstein P, Ammann RA, Krause T, Urban C, Aigner R, Gattenlöhner S, Klapper W, Mauz-Körholz C.

Pediatr Blood Cancer. 2019 Mar;66(3):e27539. doi: 10.1002/pbc.27539. Epub 2018 Nov 14.

PMID:
30426671
19.

Dual Time-Point [18F]Florbetaben PET Delivers Dual Biomarker Information in Mild Cognitive Impairment and Alzheimer's Disease.

Florek L, Tiepolt S, Schroeter ML, Berrouschot J, Saur D, Hesse S, Jochimsen T, Luthardt J, Sattler B, Patt M, Hoffmann KT, Villringer A, Classen J, Gertz HJ, Sabri O, Barthel H.

J Alzheimers Dis. 2018;66(3):1105-1116. doi: 10.3233/JAD-180522.

PMID:
30400095
20.

Central noradrenaline transporter availability is linked with HPA axis responsiveness and copeptin in human obesity and non-obese controls.

Schinke C, Hesse S, Rullmann M, Becker GA, Luthardt J, Zientek F, Patt M, Stoppe M, Schmidt E, Meyer K, Meyer PM, Orthgieß J, Blüher M, Kratzsch J, Ding YS, Then Bergh F, Sabri O.

Stress. 2019 Jan;22(1):93-102. doi: 10.1080/10253890.2018.1511698. Epub 2018 Oct 29.

PMID:
30369292
21.

Simultaneous F18-FDG-PET/MR Optimized Treatment Planning in a Young Patient with Sacro-Coccygeal Chordoma.

Roth C, Sabri O, Kluge R, Fischer L, Monecke A, Wachowiak R, Hirsch FW, Kurch L.

Klin Padiatr. 2018 Oct;230(6):326-327. doi: 10.1055/a-0715-1768. Epub 2018 Oct 1.

PMID:
30273943
22.

Combined Metabolo-Volumetric Parameters of 18F-FDG-PET and MRI Can Predict Tumor Cellularity, Ki67 Level and Expression of HIF 1alpha in Head and Neck Squamous Cell Carcinoma: A Pilot Study.

Surov A, Meyer HJ, Höhn AK, Sabri O, Purz S.

Transl Oncol. 2019 Jan;12(1):8-14. doi: 10.1016/j.tranon.2018.08.018. Epub 2018 Sep 18.

23.

Relationships between histogram analysis of ADC values and complex 18F-FDG-PET parameters in head and neck squamous cell carcinoma.

Meyer HJ, Purz S, Sabri O, Surov A.

PLoS One. 2018 Sep 6;13(9):e0202897. doi: 10.1371/journal.pone.0202897. eCollection 2018.

24.

Cervical Cancer: Associations between Metabolic Parameters and Whole Lesion Histogram Analysis Derived from Simultaneous 18F-FDG-PET/MRI.

Meyer HJ, Purz S, Sabri O, Surov A.

Contrast Media Mol Imaging. 2018 Jul 30;2018:5063285. doi: 10.1155/2018/5063285. eCollection 2018.

25.

Associations Between [18F]FDG-PET and Complex Histopathological Parameters Including Tumor Cell Count and Expression of KI 67, EGFR, VEGF, HIF-1α, and p53 in Head and Neck Squamous Cell Carcinoma.

Surov A, Meyer HJ, Höhn AK, Winter K, Sabri O, Purz S.

Mol Imaging Biol. 2019 Apr;21(2):368-374. doi: 10.1007/s11307-018-1223-x.

PMID:
29931433
26.

Quantitative Susceptibility Mapping of Amyloid-β Aggregates in Alzheimer's Disease with 7T MR.

Tiepolt S, Schäfer A, Rullmann M, Roggenhofer E; Netherlands Brain Bank, Gertz HJ, Schroeter ML, Patt M, Bazin PL, Jochimsen TH, Turner R, Sabri O, Barthel H.

J Alzheimers Dis. 2018;64(2):393-404. doi: 10.3233/JAD-180118.

PMID:
29865069
27.

Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementia.

Sabri O, Meyer PM, Gräf S, Hesse S, Wilke S, Becker GA, Rullmann M, Patt M, Luthardt J, Wagenknecht G, Hoepping A, Smits R, Franke A, Sattler B, Tiepolt S, Fischer S, Deuther-Conrad W, Hegerl U, Barthel H, Schönknecht P, Brust P.

Brain. 2018 Jun 1;141(6):1840-1854. doi: 10.1093/brain/awy099.

28.

18F-FDG PET Response of Skeletal (Bone Marrow and Bone) Involvement After Induction Chemotherapy in Pediatric Hodgkin Lymphoma: Are Specific Response Criteria Required?

Georgi TW, Kluge R, Kurch L, Chavdarova L, Hasenclever D, Stoevesandt D, Pelz T, Landman-Parker J, Wallace WH, Karlen J, Fernández-Teijeiro A, Cepelova M, Fosså A, Balwierz W, Attarbaschi A, Ammann RA, Pears J, Hraskova A, Uyttebroeck A, Beishuizen A, Dieckmann K, Leblanc T, Daw S, Baumann J, Körholz D, Sabri O, Mauz-Körholz C.

J Nucl Med. 2018 Oct;59(10):1524-1530. doi: 10.2967/jnumed.117.205633. Epub 2018 Apr 13.

29.

Noradrenaline transporter availability on [11C]MRB PET predicts weight loss success in highly obese adults.

Vettermann FJ, Rullmann M, Becker GA, Luthardt J, Zientek F, Patt M, Meyer PM, McLeod A, Brendel M, Blüher M, Stumvoll M, Hilbert A, Ding YS, Sabri O, Hesse S.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1618-1625. doi: 10.1007/s00259-018-4002-7. Epub 2018 Apr 7.

PMID:
29627935
30.

Associations Between Histogram Analysis DCE MRI Parameters and Complex 18F-FDG-PET Values in Head and Neck Squamous Cell Carcinoma.

Surov A, Leifels L, Meyer HJ, Winter K, Sabri O, Purz S.

Anticancer Res. 2018 Mar;38(3):1637-1642.

PMID:
29491096
31.

Exploring the Metabolism of (+)-[18F]Flubatine in Vitro and in Vivo: LC-MS/MS Aided Identification of Radiometabolites in a Clinical PET Study.

Ludwig FA, Fischer S, Smits R, Deuther-Conrad W, Hoepping A, Tiepolt S, Patt M, Sabri O, Brust P.

Molecules. 2018 Feb 20;23(2). pii: E464. doi: 10.3390/molecules23020464.

32.

Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.

Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS, Lleó A, Mintun MA, Wallin A, Engelborghs S, Na DL, Chételat G, Molinuevo JL, Landau SM, Mattsson N, Kornhuber J, Sabri O, Rowe CC, Parnetti L, Popp J, Fladby T, Jagust WJ, Aalten P, Lee DY, Vandenberghe R, Resende de Oliveira C, Kapaki E, Froelich L, Ivanoiu A, Gabryelewicz T, Verbeek MM, Sanchez-Juan P, Hildebrandt H, Camus V, Zboch M, Brooks DJ, Drzezga A, Rinne JO, Newberg A, de Mendonça A, Sarazin M, Rabinovici GD, Madsen K, Kramberger MG, Nordberg A, Mok V, Mroczko B, Wolk DA, Meyer PT, Tsolaki M, Scheltens P, Verhey FRJ, Visser PJ; Amyloid Biomarker Study Group, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, Barthel H, van Berckel BNM, Blennow K, van Buchem MA, Cavedo E, Chen K, Chipi E, Cohen AD, Förster S, Fortea J, Frederiksen KS, Freund-Levi Y, Gkatzima O, Gordon MF, Grimmer T, Hampel H, Hausner L, Hellwig S, Herukka SK, Johannsen P, Klimkowicz-Mrowiec A, Köhler S, Koglin N, van Laere K, de Leon M, Lisetti V, Maier W, Marcusson J, Meulenbroek O, Møllergård HM, Morris JC, Nordlund A, Novak GP, Paraskevas GP, Perera G, Peters O, Ramakers IHGB, Rami L, Rodríguez-Rodríguez E, Roe CM, Rot U, Rüther E, Santana I, Schröder J, Seo SW, Soininen H, Spiru L, Stomrud E, Struyfs H, Teunissen CE, Vos SJB, van Waalwijk van Doorn LJC, Waldemar G, Wallin ÅK, Wiltfang J, Zetterberg H.

JAMA Psychiatry. 2018 Jan 1;75(1):84-95. doi: 10.1001/jamapsychiatry.2017.3391. Erratum in: JAMA Psychiatry. 2018 Mar 1;75(3):303.

33.

Validation of Noninvasive Tracer Kinetic Analysis of 18F-Florbetaben PET Using a Dual-Time-Window Acquisition Protocol.

Bullich S, Barthel H, Koglin N, Becker GA, De Santi S, Jovalekic A, Stephens AW, Sabri O.

J Nucl Med. 2018 Jul;59(7):1104-1110. doi: 10.2967/jnumed.117.200964. Epub 2017 Nov 24.

34.

Associations between 18F-FDG-PET, DWI, and DCE Parameters in Patients with Head and Neck Squamous Cell Carcinoma Depend on Tumor Grading.

Leifels L, Purz S, Stumpp P, Schob S, Meyer HJ, Kahn T, Sabri O, Surov A.

Contrast Media Mol Imaging. 2017 Oct 19;2017:5369625. doi: 10.1155/2017/5369625. eCollection 2017.

35.

In vivo staging of regional amyloid deposition.

Grothe MJ, Barthel H, Sepulcre J, Dyrba M, Sabri O, Teipel SJ; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2017 Nov 14;89(20):2031-2038. doi: 10.1212/WNL.0000000000004643. Epub 2017 Oct 18.

36.

Combined PET/MRI: Global Warming-Summary Report of the 6th International Workshop on PET/MRI, March 27-29, 2017, Tübingen, Germany.

Bailey DL, Pichler BJ, Gückel B, Antoch G, Barthel H, Bhujwalla ZM, Biskup S, Biswal S, Bitzer M, Boellaard R, Braren RF, Brendle C, Brindle K, Chiti A, la Fougère C, Gillies R, Goh V, Goyen M, Hacker M, Heukamp L, Knudsen GM, Krackhardt AM, Law I, Morris JC, Nikolaou K, Nuyts J, Ordonez AA, Pantel K, Quick HH, Riklund K, Sabri O, Sattler B, Troost EGC, Zaiss M, Zender L, Beyer T.

Mol Imaging Biol. 2018 Feb;20(1):4-20. doi: 10.1007/s11307-017-1123-5.

37.

Additive value of amyloid-PET in routine cases of clinical dementia work-up after FDG-PET.

Brendel M, Schnabel J, Schönecker S, Wagner L, Brendel E, Meyer-Wilmes J, Unterrainer M, Schildan A, Patt M, Prix C, Ackl N, Catak C, Pogarell O, Levin J, Danek A, Buerger K, Bartenstein P, Barthel H, Sabri O, Rominger A.

Eur J Nucl Med Mol Imaging. 2017 Dec;44(13):2239-2248. doi: 10.1007/s00259-017-3832-z. Epub 2017 Sep 20.

PMID:
28932894
38.

Clinical Use and Utility of Amyloid Imaging.

Barthel H, Sabri O.

J Nucl Med. 2017 Nov;58(11):1711-1717. doi: 10.2967/jnumed.116.185017. Epub 2017 Aug 17. Review.

39.

Brain PET and functional MRI: why simultaneously using hybrid PET/MR systems?

Cecchin D, Palombit A, Castellaro M, Silvestri E, Bui F, Barthel H, Sabri O, Corbetta M, Bertoldo A.

Q J Nucl Med Mol Imaging. 2017 Dec;61(4):345-359. doi: 10.23736/S1824-4785.17.03008-4. Epub 2017 Jul 27. Review.

PMID:
28750494
40.

The association between in vivo central noradrenaline transporter availability and trait impulsivity.

Hesse S, Müller U, Rullmann M, Luthardt J, Bresch A, Becker GA, Zientek F, Patt M, Meyer PM, Blüher M, Strauß M, Fenske W, Hankir M, Ding YS, Hilbert A, Sabri O.

Psychiatry Res Neuroimaging. 2017 Sep 30;267:9-14. doi: 10.1016/j.pscychresns.2017.06.013. Epub 2017 Jun 23.

PMID:
28675825
41.

Serotonin transporter gene promoter methylation status correlates with in vivo prefrontal 5-HTT availability and reward function in human obesity.

Drabe M, Rullmann M, Luthardt J, Boettcher Y, Regenthal R, Ploetz T, Becker GA, Patt M, Schinke C, Bergh FT, Zientek F, Hilbert A, Bresch A, Fenske W, Hankir MK, Sabri O, Hesse S.

Transl Psychiatry. 2017 Jul 4;7(7):e1167. doi: 10.1038/tp.2017.133.

42.

A new integrated dual time-point amyloid PET/MRI data analysis method.

Cecchin D, Barthel H, Poggiali D, Cagnin A, Tiepolt S, Zucchetta P, Turco P, Gallo P, Frigo AC, Sabri O, Bui F.

Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):2060-2072. doi: 10.1007/s00259-017-3750-0. Epub 2017 Jul 4.

PMID:
28674847
43.

Hunger and disinhibition but not cognitive restraint are associated with central norepinephrine transporter availability.

Bresch A, Rullmann M, Luthardt J, Becker GA, Patt M, Ding YS, Hilbert A, Sabri O, Hesse S.

Appetite. 2017 Oct 1;117:270-274. doi: 10.1016/j.appet.2017.06.020. Epub 2017 Jun 21.

PMID:
28647385
44.

Comparison of volumetric and functional parameters in simultaneous cardiac PET/MR: feasibility of volumetric assessment with residual activity from prior PET/CT.

Lücke C, Oppolzer B, Werner P, Foldyna B, Lurz P, Jochimsen T, Brenneis B, Lehmkuhl L, Sattler B, Grothoff M, Barthel H, Sabri O, Gutberlet M.

Eur Radiol. 2017 Dec;27(12):5146-5157. doi: 10.1007/s00330-017-4896-7. Epub 2017 Jun 19.

45.

Optimized classification of 18F-Florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment.

Bullich S, Seibyl J, Catafau AM, Jovalekic A, Koglin N, Barthel H, Sabri O, De Santi S.

Neuroimage Clin. 2017 May 13;15:325-332. doi: 10.1016/j.nicl.2017.04.025. eCollection 2017.

46.

Maternal immune activation results in complex microglial transcriptome signature in the adult offspring that is reversed by minocycline treatment.

Mattei D, Ivanov A, Ferrai C, Jordan P, Guneykaya D, Buonfiglioli A, Schaafsma W, Przanowski P, Deuther-Conrad W, Brust P, Hesse S, Patt M, Sabri O, Ross TL, Eggen BJL, Boddeke EWGM, Kaminska B, Beule D, Pombo A, Kettenmann H, Wolf SA.

Transl Psychiatry. 2017 May 9;7(5):e1120. doi: 10.1038/tp.2017.80.

47.

Feasibility of in vivo 18F-florbetaben PET/MR imaging of human carotid amyloid-β.

Bucerius J, Barthel H, Tiepolt S, Werner P, Sluimer JC, Wildberger JE, Patt M, Hesse S, Gertz HJ, Biessen EAL, Mottaghy FM, Sabri O.

Eur J Nucl Med Mol Imaging. 2017 Jul;44(7):1119-1128. doi: 10.1007/s00259-017-3651-2. Epub 2017 Mar 21.

48.

Test-retest measurements of dopamine D1-type receptors using simultaneous PET/MRI imaging.

Kaller S, Rullmann M, Patt M, Becker GA, Luthardt J, Girbardt J, Meyer PM, Werner P, Barthel H, Bresch A, Fritz TH, Hesse S, Sabri O.

Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1025-1032. doi: 10.1007/s00259-017-3645-0. Epub 2017 Feb 14.

PMID:
28197685
49.

Yes we can analyse amyloid images - Now What?

Barthel H, Seibyl J, Sabri O.

Eur J Nucl Med Mol Imaging. 2017 May;44(5):822-824. doi: 10.1007/s00259-017-3644-1. No abstract available.

PMID:
28184971
50.

Post-dexamethasone serum copeptin corresponds to HPA axis responsiveness in human obesity.

Schinke C, Hesse S, Stoppe M, Meyer K, Schmidt E, Orthgiess J, Bechmann L, Bresch A, Rullmann M, Luthardt J, Sabri O, Blüher M, Kratzsch J, Then Bergh F.

Psychoneuroendocrinology. 2017 Apr;78:39-47. doi: 10.1016/j.psyneuen.2017.01.004. Epub 2017 Jan 16.

PMID:
28167369

Supplemental Content

Support Center